Chandra Bhagat Pharma (BOM:542934) EPS (Basic): ₹4.04 (TTM As of Mar. 2026)


BOM:542934 Chandra Bhagat Pharma Ltd BOM:542934
65 GF Score
Price ₹43.89
GF Value ₹70.23
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Chandra Bhagat Pharma EPS (Basic)?

Chandra Bhagat Pharma BOM:542934 65 EPS (Basic) is ₹4.04 as of Mar. 2026. GuruFocus rates BOM:542934 with a GF Score™ of 65/100 and a GF Value™ of ₹70.23 (Possible Value Trap). The stock has 4 warning signs investors should review.

Chandra Bhagat Pharma's basic earnings per share (Basic EPS) for the six months ended in Mar. 2026 was ₹3.44. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹4.04.

Chandra Bhagat Pharma's EPS (Diluted) for the six months ended in Mar. 2026 was ₹3.44. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹4.04.

Chandra Bhagat Pharma's EPS without NRI for the six months ended in Mar. 2026 was ₹3.44. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 4.04.

During the past 12 months, Chandra Bhagat Pharma's average EPS without NRIGrowth Rate was 254.40% per year. During the past 3 years, the average EPS without NRI Growth Rate was 27.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was 35.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 10 years, Chandra Bhagat Pharma's highest 3-Year average EPS without NRI Growth Rate was 77.90% per year. The lowest was -41.80% per year. And the median was 27.30% per year.

Chandra Bhagat Pharma  (BOM:542934) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Chandra Bhagat Pharma EPS (Basic) Related Terms

Chandra Bhagat Pharma EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Chandra Bhagat Pharma's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chandra Bhagat Pharma EPS (Basic) Chart

Chandra Bhagat Pharma Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.06 1.20 2.03 1.14 4.04

Chandra Bhagat Pharma Semi-Annual Data
Mar17 Mar18 Mar19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.19 0.91 0.23 0.60 3.44
BOM:542934
65GF Score
Chandra Bhagat Pharma Ltd BOM:542934
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chandra Bhagat Pharma EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Chandra Bhagat Pharma's Basic EPS for the fiscal year that ended in Mar. 2026 is calculated as

Basic EPS (A: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(30.461-0)/7.540
=4.04

Chandra Bhagat Pharma's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(25.97-0)/7.549
=3.44

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹4.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ₹4.04 mean?
Chandra Bhagat Pharma (BOM:542934) has a EPS (Basic) of ₹4.04 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Chandra Bhagat Pharma and its competitors.
Is Chandra Bhagat Pharma's EPS (Basic) too high?
Chandra Bhagat Pharma's current EPS (Basic) is ₹4.04. Overall, Chandra Bhagat Pharma has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Chandra Bhagat Pharma's EPS (Basic) compare to MCK and COR?
Chandra Bhagat Pharma's EPS (Basic) of ₹4.04 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Medical Distribution company?
A good EPS (Basic) depends on the Medical Distribution industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Chandra Bhagat Pharma and its competitors. Chandra Bhagat Pharma's current EPS (Basic) is ₹4.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chandra Bhagat Pharma stock overvalued right now?
Based on GuruFocus' analysis, Chandra Bhagat Pharma (BOM:542934) is currently considered Possible Value Trap. The stock's GF Value™ is ₹70.23, compared to a current price of ₹43.89 — trading 37.5% below its estimated fair value. The current EPS (Basic) is ₹4.04. Chandra Bhagat Pharma's overall GF Score™ is 65/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Chandra Bhagat Pharma (BOM:542934), the current EPS (Basic) is ₹4.04 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Chandra Bhagat Pharma (BOM:542934) Overvalued in 2026?

Based on GuruFocus' analysis, Chandra Bhagat Pharma stock appears to be undervalued. The current stock price of ₹43.89 is trading 37.5% below its estimated GF Value™ of ₹70.23. GuruFocus considers Chandra Bhagat Pharma to be Possible Value Trap.

Key valuation signals for BOM:542934:

  • EPS (Basic): ₹4.04
  • GF Value™: ₹70.23 vs. price of ₹43.89 (37.5% below fair value)
  • GF Score™: 65/100 with 4 warning signs

No single metric tells the full story. See the BOM:542934 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Chandra Bhagat Pharma Business Description

Address Doctor Ambedkar Road, 323-F, Flat 1,2, Bhagat Bhuvan, Matunga East, Mumbai, MH, IND, 400019
Chandra Bhagat Pharma Ltd is a pharmaceutical company marketing pharmaceutical, critical care, and health care products across the globe. The company deals in many categories of pharmaceutical products like anticancer, cardiovascular, anti-infective, etc. It offers various forms of pharmaceutical products, like oral solids. tablets, capsules, liquid orals, syrup suspension, injections, liquid, powder, etc. Additionally, the company is also engaged in promoting and marketing of Active Pharmaceutical Ingredients (API's) in India.
65GF Score

Get the complete analysis for BOM:542934

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹43.89
Price
₹70.23
GF Value